Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Synthesis, biological profiling and determination of the tubulin-bound conformation of 12-Aza-epothilones (azathilones)

  • Jantsch, Andrea
  • Nieto, Lidia
  • Gertsch, Jürg
  • Rodríguez-Salarichs, Javier
  • Matesanz, Ruth
  • Jiménez-Barbero, Jesús
  • Díaz, José Fernando
  • Canales, Ángeles
  • Altmann, Karl-Heinz
26 p.-6 fig.2 tab., 12-Aza-epothilones (azathilones) incorporating quinoline side chains and bearing different N12-substituents have been synthesized via highly efficient RCM-based macrocyclizations.Quinoline-based azathilones with the side chain N-atom in the meta-position to the C15 atom in the macrocycle are highly potent inhibitors of cancer cell growth in vitro. In contrast, shifting the quinoline nitrogen to the position para to C15 leads to a ca. 1000-fold loss in potency. Likewise,the desaturation of the C9-C10 bond in the macrocycle to an E double bond produces a substantial reduction in antiproliferative activity. This is in stark contrast to the effect exerted by the same modification in the natural epothilone macrocycle. The conformation of a representative azathilone bound to / -tubulin heterodimers was determined based on TR-NOE measurements and a model for the posture of the compound in its binding site on -tubulin was deduced through a combination of STD measurements and CORCEMA-ST calculations. The tubulin-bound, bioactive conformation of azathilones was found to be overall similar to that of epothilones A and B., This work was supported by an institutional grant from the ETH Zürich (A.J., K-H.A.,J.G.), by MICIN through grant CTQ-2006-10874-C002-01 (J.J.B.), by FPI through grant BES-2007-16429 (L.N.),by the Spanish MINECO through a “Ramon y Cajal” postdoctoral contract and project grants CTQ2012-32025, SAF 2013-48271-C2-IR, and SAF 2010-22198-C02-01 (A.C.), and by grants BIO2013-42984-R from Ministerio de Economia y Competitividad, and grant S2010/BMD-2457 BIPEDD2 from Comunidad Autónoma de Madrid, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Deconvolution of Buparlisib’s mechanism of action defines specific PI3K and tubulin inhibitors for therapeutic intervention

  • Bohnacker, Thomas
  • Díaz, José Fernando
  • Wymann, Matthias P.
13 p.-7 fig. Bohnacker, Thomas et al., BKM120 (Buparlisib) is one of the most advanced phosphoinositide 3-kinase (PI3K) inhibitors for the treatment of cancer, but it interferes as an off-target effect with microtubule polymerization. Here, we developed two chemical derivatives that differ from BKM120 by only one atom.We show that these minute changes separate the dual activity of BKM120 into discrete PI3K and tubulin inhibitors. Analysis of the compounds cellular growth arrest phenotypes and microtubule dynamics suggest that the antiproliferative activity of BKM120 is mainly due to microtubule-dependent cytotoxicity rather than through inhibition of PI3K.Crystal structures of BKM120 and derivatives in complex with tubulin and PI3K provide insights into the selective mode of action of this class of drugs. Our results raise concerns over BKM120’s generally accepted mode of action, and provide a unique mechanistic basis for next-generation PI3K inhibitors with improved safety profiles and flexibility for use in combination therapies., This work was supported by the Swiss Commission for Technology and Innovation (CTI) by PFLS-LS grants 14032.1,15811.2 and 17241.1; the Stiftung für Krebsbekämpfung grant 341, Swiss National Science Foundation grants 310030_153211 and 316030_133860 (to M.P.W.), and 310030B_138659 and 31003A_166608 (to M.O.S.); in part by European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement 675392, and grants BIO2013-42984-R (Ministerio de Economia y Competitividad), S2010/BMD-2457 BIPEDD2 (Comunidad Autónoma de Madrid) to J.F.D.; and by the MRC to R.L.W. (U105184308, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Modification of C-seco taxoids through ring tethering and substituent replacement leading to effective agents against tumor drug resistance mediated by βIII-Tubulin and P-glycoprotein (P-gp) overexpressions.

  • Tang, Yong
  • Rodríguez-Salarichs, Javier
  • Estévez-Gallego, Juan
  • Balaguer, Francisco de Asís
  • Redondo-Horcajo, Mariano
  • Lucena-Agell, Daniel
  • Barasoain, Isabel
  • Díaz, José Fernando
  • Fang, Wei-Shuo
53 p.-6 fig.-3 tab.-1 graf. Tang, Yong et al., In our efforts to improve the efficacy of taxane-based microtubule (MT) stabilizing agents against tumor drug resistance mediated by multiple mechanisms, two clinically relevant factors were focused: i.e., P-glycoprotein and βIII-tubulin overexpression. Based on the structure of C-seco taxoid 1 m (IDN5390) which was believed to more selectively interact with βIII-tubulin than paclitaxel, we prepared a series of C-seco taxoids bearing various 7,9-O-linkages and/or different substituents at C2 and C3′ positions. Some of them exhibited much more potent binding affinity to MTs and cytotoxicity than their C-seco parent compounds in drug resistant cells with both mechanisms. SAR analysis indicated that C2 modifications significantly enhanced MT binding but brought ambiguous influence to cytotoxicity whereas 7,9-linkage and C3′ modifications enhance cytotoxicity more efficiently than improve MT binding. These observations illustrate a better translation of molecular binding effect to cellular activity by C ring closure and C3′ modification than C2 modification in C-seco taxoids., This research was supported by NSFC (Grant No. 30930108) to (W.-S.F.), and by BIPPED2 (S2010/BMD-2457) (J.F.D.), project of the Comunidad de Madrid and the BIO2013-42984R (to J.F.D.) project from the Ministry of Economy and Competitiveness of Spain., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structural Determinants of the Dictyostatin Chemotype for Tubulin Binding Affinity and Antitumor Activity Against Taxane- and Epothilone-Resistant Cancer Cells

  • Trigili, Chiara
  • Barasoain, Isabel
  • Sánchez-Murcia, Pedro A.
  • Bargsten, Katja
  • Redondo-Horcajo, Mariano
  • Nogales, Aurora
  • Gardner, Nicola M.
  • Meyer, Arndt
  • Naylor, Guy J.
  • Gomez-Rubio, Elena
  • Gago, Federico
  • Steinmetz, Michel O.
  • Paterson, Ian
  • Prota, Andrea E.
  • Díaz, José Fernando
13 p.-5 fig.-2 tab.-1 graph.abst., A combined biochemical, structural, and cell biology characterization of dictyostatin is described, which enables an improved understanding of the structural determinants responsible for the high-affinity binding of this anticancer agent to the taxane site in microtubules (MTs). The study reveals that this macrolide is highly optimized for MT binding and that only a few of the structural modifications featured in a library of synthetic analogues resulted in small gains in binding affinity. The high efficiency of the dictyostatin chemotype in overcoming various kinds of clinically relevant resistance mechanisms highlights its potential for therapeutic development for the treatment of drug-resistant tumors. A structural explanation is advanced to account for the synergy observed between dictyostatin and taxanes on the basis of their differential effects on the MT lattice. The X-ray crystal structure of a tubulin–dictyostatin complex and additional molecular modeling have allowed the rationalization of the structure–activity relationships for a set of synthetic dictyostatin analogues, including the highly active hybrid 12 with discodermolide. Altogether, the work reported here is anticipated to facilitate the improved design and synthesis of more efficacious dictyostatin analogues and hybrids with other MT-stabilizing agents., This work was supported in part by grants BIO2013-42984-R (J.F.D.) and SAF2012-39760-C02-02 (F.G.) from Ministerio de Economía y Competitividad, grant S2010/BMD-2457 BIPEDD2 from Comunidad Autónoma de Madrid (F.G. and J.F.D.), and the Swiss National Science Foundation grants 310030B_138659 and 31003A_166608 (M.O.S.). The authors acknowledge networking contribution by the COST Action CM1407 “Challenging organic syntheses inspired by nature—from natural products chemistry to drug discovery” and the COST action CM1470. I.P. thanks the EPSRC and AstraZeneca for funding, Dr. John Leonard (AstraZeneca) for useful discussions, Dr. Stuart Mickel (Novartis) for the provision of chemicals, and the EPSRC UK National Mass Spectrometry Facility at Swansea University for mass spectra.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Aggregated compound biological signatures facilitate phenotypic drug discovery and target elucidation

  • Cortés Cabrera, Álvaro
  • Lucena-Agell, Daniel
  • Redondo-Horcajo, Mariano
  • Barasoain, Isabel
  • Díaz, José Fernando
  • Fasching, Bernhard
  • Petrone, Paula M.
Predicting the cellular response of compounds is a challenge central to the discovery of new drugs. Compound biological signatures have risen as a way of representing the perturbation produced by a compound in the cell. However, their ability to encode specific phenotypic information and generating tangible predictions remains unknown, mainly because of the inherent noise in such data sets. In this work, we statistically aggregate signals from several compound biological signatures to find compounds that produce a desired phenotype in the cell. We exploit this method in two applications relevant for phenotypic screening in drug discovery programs: target-independent hit expansion and target identification. As a result, we present here (i) novel nanomolar inhibitors of cellular division that reproduce the phenotype and the mode of action of reference natural products and (ii) blockers of the NKCC1 cotransporter for autism spectrum disorders. Our results were confirmed in both cellular and biochemical assays of the respective projects. In addition, these examples provided novel insights on the information content and biological significance of compound biological signatures from HTS, and their applicability to drug discovery in general. For target identification, we show that novel targets can be predicted successfully for drugs by reporting new activities for nimedipine, fluspirilene, and pimozide and providing a rationale for repurposing and side effects. Our results highlight the opportunities of reusing public bioactivity data for prospective drug discovery, including scenarios where the effective target or mode of action of a particular molecule is not known, such as in phenotypic screening campaigns., A.C.C. and P.M.P. gratefully acknowledge the Roche Postdoctoral Fellowship Program for financial support. The authors thank especially Martin Erkens, Rene Wyler, Thilo Enderle, Lisa Sach-Peltason, Samuel Croset, and Oliv Eidam for their help and thoughtful comments and Klaus Muller for his support and invaluable insight. Eurofins’ (CEREP) is gratefully acknowledged for providing us with single concentration activities from the BioPrint database in advantageous conditions. F.D., D.L.A., M.R.H., and I.B. acknowledge support from grants BIO2013-42984-R (Ministerio de Economia y Competitividad) and S2010/BMD-2457 BIPEDD2 (Comunidad Autónoma de Madrid (JFD)).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Synthesis and Anti-Proliferative Activity of Sulfanyltriazolylnaphthalenols and Sulfanyltriazolylnaphthalene-1,4-diones

  • Chaaban, Ibrahim
  • El Khawass, El Sayeda M.
  • Abd El Razik, Heba A.
  • El Salamouni, Nehad S.
  • Redondo-Horcajo, Mariano
  • Barasoain, Isabel
  • Díaz, José Fernando
  • Yli-Kauhaluoma, Jari
  • Moreira, Vânia M.
A series of new sulfanyltriazolylnaphthalenols (10a–f and 13a–f) and sulfanyltriazolylnaphthalene-1,4-diones (14a–f) were synthesized and evaluated against a panel of cancer cell lines. Among the tested compounds, 10b and 10d showed the best anti-proliferative activity with GI values ranging from 2.72 to 10 and 3.13 to 13.1 µM, respectively, in several of the tumor cell lines tested. Compound 10d is highly selective toward leukemia cell lines and can be regarded as a good model for the development of new anti-leukemic agents., The authors thank the National Cancer Institute (NCI), Bethesda, Maryland, USA (http://dtp.cancer.gov/) for performing the in vitro anticancer screening of the compounds. Part of the biological work has been supported by the BIPPED2 (grant S2010/BMD-2457 to J.F.D.), by the Comunidad de Madrid and by the MINECO (grant BIO2013-42984-R) to J.F.D. We further thank P. Lastres for his help with flow cytometry. V.M.M. thanks the Magnus Ehrnrooth Foundation, Helsinki, Finland, for financial support (grant ME2012n44).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structural and Biochemical Characterization of the Interaction of Tubulin with Potent Natural Analogues of Podophyllotoxin

  • Antúnez-Mojica, Mayra
  • Rodríguez-Salarichs, Javier
  • Redondo-Horcajo, Mariano
  • León, Alejandra
  • Barasoain, Isabel
  • Canales, Ángeles
  • Cañada, F. Javier
  • Jiménez-Barbero, Jesús
  • Álvarez, Laura
  • Díaz, José Fernando
Four natural analogues of podophyllotoxin obtained from the Mexican medicinal plant Bursera fagaroides, namely, acetyl podophyllotoxin (2), 5′-desmethoxy-β-peltatin A methyl ether (3), 7′,8′-dehydro acetyl podophyllotoxin (4), and burseranin (5), have been characterized, and their interactions with tubulin have been investigated. Cytotoxic activity measurements, followed by immunofluorescence microscopy and flow cytometry studies, demonstrated that these compounds disrupt microtubule networks in cells and cause cell cycle arrest in the G2/M phase in the A549 cell line. A tubulin binding assay showed that compounds 1-4 were potent assembly inhibitors, displaying binding to the colchicine site with K values ranging from 11.75 to 185.0 × 10 M. In contrast, burseranin (5) was not able to inhibit tubulin assembly. From the structural perspective, the ligand-binding epitopes of compounds 1-3 have been mapped using STD-NMR, showing that B and E rings are the major points for interaction with the protein. The obtained results indicate that the inhibition of tubulin assembly of this family of compounds is more effective when there are at least two methoxyl groups at the E ring, along with a trans configuration of the lactone ring in the aryltetralin lignan core., M.A.-M. is grateful to CONACyT for providing fellowship 253315. Partial financial support from CONACYT, Mexico ́ (Grant 240801), Ministerio de Economia y Competitividad, Españ a (Grant BIO2013-42984-R), and Comunidad Autonoma ́ de Madrid (J.F.D., Grant S2010/BMD-2457 BIPEDD2) is acknowledged. The authors thank Laboratorio Nacional de Estructura de Macromoleculas (Conacyt 251613) for the ́ spectroscopic and mass analyses, and B. E. Dominguez Mendoza for her useful suggestions and comments on the manuscript. We thank Matadero INCOVA (Segovia) for calf brains for tubulin purification and Prof. J. M. Andreu for MTC and useful discussions and suggestions. The authors acknowledge networking contribution by the COST Action CM1407 “Challenging organic syntheses inspired b
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Total Synthesis of Amphidinolide K, a Macrolide That Stabilizes F-Actin

  • Sánchez, Dani
  • Andreou, Thanos
  • Costa, Anna M.
  • Meyer, Kevin G.
  • Williams, David R.
  • Barasoain, Isabel
  • Díaz, José Fernando
  • Lucena-Agell, Daniel
  • Vilarrasa, Jaume
The total synthesis of (-)-amphidinolide K (1) based on asymmetric addition of allylsilane C1-C8 to enal C9-C22 is reported. The 1,9,18-tris-O-TBDPS ether was converted into the desired 9,18-dihydroxy acid. Its macrolactonization was accomplished by the Shiina method. Compound 1 together with some of its stereoisomers and analogues were subjected to evaluation of the possible disruption of the α,β-tubulin-microtubule and/or G-actin-F-actin equilibria. Compound 1 behaves as a stabilizer of actin filaments (F-actin) in vitro., Grant Nos. CTQ2006-15393, CTQ2009-13590, CTQ2012-39230 (Spanish Government, FEDER), and 2009SGR825 (AGAUR, Barcelona) are acknowledged. D.S. was an UB Ph.D. student (2011–2014) and is currently (since January 2015) a fellow of the Fundació Cellex de Barcelona. T.A. had a Ph.D. studentship from AGAUR (Generalitat de Catalunya, 2003–2006) and later from Fundació Bosch Gimpera (UB, 2007). D.R.W. gratefully acknowledges the National Institutes of Health (GM-42897). Grant No. BIO2013-42984-R from the Spanish Government to J.F.D. is also acknowledged. The cover illustration is an oil painting by Núria Hereu.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Mechanism of the Interactions of Pironetin Analog/Combretastatin A-4 Hybrids with Tubulin

  • Torijano-Gutiérrez, Sandra
  • Vilanova, Concepción
  • Díaz-Oltra, Santiago
  • Murga, Juan
  • Falomir, Eva
  • Carda, Miguel
  • Redondo-Horcajo, Mariano
  • Díaz, José Fernando
  • Barasoain, Isabel
  • Marco, J. Alberto
We here report an investigation of the interactions with tubulin of two types of molecules of a hybrid structural type consisting in a combretastatin A-4 moiety and a simplified pironetin fragment. The cytotoxicities of the molecules on two reference tumoral cell lines were measured. In addition, the effects of the compounds on the cell cycle and on microtubule assembly were observed. The dynamics of microtubule polymerization was investigated by means of immunofluorescence assays. It was thus established that at least some of the compounds under study exert their cytotoxic action by means of interaction with tubulin. The interactions with tubulin of several cytotoxic pironetin analog/combretastatin A-4 hybrids were investigated. Even though the natural products pironetin and combretastatin A-4 are known to interact with tubulin at different sites, only some of the synthetic hybrid molecules show such type of interactions, which are in addition dependent on the length of the spacer fragment., Financial support to the research has been granted by the Spanish Government (MINECO, Ministerio de Economía y Competitividad, research grants CTQ2008-02800 and CTQ2011-27560), by the Consellería d'Empresa, Universitat i Ciencia de la Generalitat Valenciana (research grants PROMETEO/2013/027, ACOMP09/113 and ACOMP/2014/272) and by the Universitat Jaume I (research grants P1-1B-2008-14 and PI-1B-2011-37). C.V. thanks the MINECO for a predoctoral fellowship of the FPI program. Part of the biological work has been supported by the BIPPED2 (grant S2010/BMD-2457 to J.F.D.), by the Comunidad de Madrid and by the MINECO (grant BIO2013-42984-R) to J.F.D. We further thank Prof. C. M. Cerda García-Rojas, from the Departamento de Química, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico, for the kind sending of pironetin samples; P. Lastres for his help with flow cytometry; and the Matadero Municipal Vicente de Lucas in Segovia for providing the calf brains which were the source of tubulin.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Synthesis, Characterization, and Application in HeLa Cells of an NIR Light Responsive Doxorubicin Delivery System Based on NaYF4:Yb,Tm@SiO2-PEG Nanoparticles

  • Alonso-Cristóbal, Paulino
  • Oton-Fernández, Olalla
  • Méndez-González, Diego
  • Díaz, José Fernando
  • López-Cabarcos, Enrique
  • Barasoain, Isabel
  • Rubio-Retama, Jorge
Herein, we present a phototriggered drug delivery system based on light responsive nanoparticles, which is able to release doxorubicin upon NIR light illumination. The proposed system is based on upconversion fluorescence nanoparticles of β-NaYF<inf>4</inf>:Yb,Tm@SiO<inf>2</inf>-PEG with a mean diameter of 52 ± 2.5 nm that absorb the NIR light and emit UV light. The UV radiation causes the degradation of photodegradable ortho-nitrobenzyl alcohol derivates, which are attached on one side to the surface of the nanoparticles and on the other to doxorubicin. This degradation triggers the doxorubicin release. This drug delivery system has been tested "in vitro" with HeLa cells. The results of this study demonstrated that this system caused negligible cytotoxicity when they were not illuminated with NIR light. In contrast, under NIR light illumination, the HeLa cell viability was conspicuously reduced. These results demonstrated the suitability of the proposed system to control the release of doxorubicin via an external NIR light stimulus., Mineco for the grants MAT2014-55065R and BIO2013-42984R and Comunidad de Madrid for the Grant S2010/BMD-2457 are gratefully acknowledged. P.A.C. acknowledges the Spanish Ministry of Education for FPU Grant No. AP2010-1163. E.L.C. would also like to thank the EU COST action CM1101. We wish to thank Ailyn Martinez for her technical assistance.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Design and synthesis of pironetin analogue/colchicine hybrids and study of their cytotoxic activity and mechanisms of interaction with tubulin

  • Vilanova, Concepción
  • Díaz-Oltra, Santiago
  • Murga, Juan
  • Falomir, Eva
  • Carda, Miguel
  • Redondo-Horcajo, Mariano
  • Díaz, José Fernando
  • Barasoain, Isabel
  • Marco, J. Alberto
We here report the synthesis of a series of 12 hybrid molecules composed of a colchicine moiety and a pironetin analogue fragment. The two fragments are connected through an ester-amide spacer of variable length. The cytotoxic activities of these compounds and their interactions with tubulin have been investigated. Relations between the structure and activity are discussed. Since the spacer is not long enough to permit a simultaneous binding of the hybrid molecules to the colchicine and pironetin sites on tubulin, a further feature investigated was whether these molecules would interact with the latter through the pironetin end (irreversible covalent binding) or through the colchicine end (reversible noncovalent binding). It has been found that binding to tubulin may take place preferentially at either of these ends depending on the length of the connecting spacer., Financial support has been granted by the Spanish Government (MINECO, Ministerio de Economía y Competitividad; Research Grants CTQ2008-02800 and CTQ2011-27560), by the Consellería d’Empresa, Universitat i Ciencia de la Generalitat Valenciana (Research Grants PROMETEO/2013/027, ACOMP09/113, and ACOMP/2014/272), and by the Universitat Jaume I (Research Grants P1-1B-2008-14 and PI-1B-2011-37). C.V. thanks the MINECO for a predoctoral fellowship of the FPI program. Part of the biological work has been supported by the BIPPED2 (Grant S2010/BMD-2457 to J.F.D.), by the Comunidad de Madrid, and by the MINECO (Grant BIO2013-42984-R to J.F.D.). We further thank Prof. C. M. Cerda García-Rojas, from the Departamento de Química, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico, for kindly sending the pironetin samples, P. Lastres for his help with flow cytometry, and the Matadero Municipal Vicente de Lucas in Segovia for providing the calf brains which were the source of tubulin.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Synthesis and biological evaluation of new oxadiazoline-substituted naphthalenyl acetates as anticancer agents

  • Chaaban, Ibrahim
  • El Khawass, El Sayeda M.
  • Abd El Razik, Heba A.
  • El Salamouni, Nehad S.
  • Redondo-Horcajo, Mariano
  • Barasoain, Isabel
  • Díaz, José Fernando
  • Yli-Kauhaluoma, Jari
  • Moreira, Vânia M.
A series of new oxadiazoline-substituted naphthalenyl acetates 3a-e and oxadiazoline-substituted 4-methoxynaphthalenyl acetates 7b-e were synthesized and tested by the National Cancer Institute (NCI) for their in vitro anticancer activity. The two derivatives bearing acetoxy groups at the 1 and 3 positions of the phenyl ring 3c and 7c were the most active showing significant anticancer activity against all tested cancer cell lines, with GI50 values ranging from 0.175 to 3.91 μM, and 0.306-11.7 μM, respectively. The selectivity of compound 3c was greater for non-solid tumor cell lines. Computational prediction of molecular and pharmacokinetic properties revealed that both compounds are safe and compound 7c had a good drug-likeness score., Part of the biological work has been supported by the BIPPED2 (grant S2010/BMD-2457 to J.F.D.), by the Comunidad de Madrid and by the MINECO (grant BIO2013-42984-R) to J.F.D. We further thank P. Lastres for his help with flow cytometry. We are thankful to Magnus Ehrnrooth Foundation (ME2012n44) for financial support.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The impact of cyclopropane configuration on the biological activity of cyclopropyl-epothilones

  • Gaugaz, Fabienne Z.
  • Redondo-Horcajo, Mariano
  • Barasoain, Isabel
  • Díaz, José Fernando
  • Cobos-Correa, Amanda
  • Kaufmann, Markus
  • Altmann, Karl-Heinz
Two cis-12,13-cyclopropyl-epothilone B variants have been synthesized, differing only in the configuration of the stereocenters at C12 and C13. The syntheses were based on a common allylic alcohol intermediate that was converted into the corresponding diastereomeric hydroxymethyl-cyclopropanes by means of stereoselective Charette cyclopropanations. Macrocyclizations were accomplished through ring-closing metathesis (RCM). Substantial differences between the two compounds were found with regard to microtubule binding affinity, antiproliferative activity and their effects on the cellular microtubule network. While the analogue with the cyclopropane moiety oriented in a corresponding way to the epoxide configuration in natural epothilones was almost equipotent with epothilone A, the other was significantly less active. Based on these findings, natural epothilone-like activity of cis-fused 12,13-cyclopropyl-epothilone analogues is tightly linked to the natural orientation of the cyclopropane moiety., K.H.A. and F.Z.G. are indebted to the Swiss National Science Foundation (SNF) (project 205320-117594) and ETH Zürich for generous financial support. J.F.D. acknowledges financial support by the Ministerio de Economia of Spain and from the Comunidad de Madrid (projects BIO2013-42984-R and S2010/BMD-2457 BIPPED, respectively).